Point72 Middle East FZE »

Kura Oncology shares owned by Point72 Middle East FZE

Quarter-by-quarter ownership of Kura Oncology (KURA) shares owned by Point72 Middle East FZE from 13F filings

Historical chart of Point72 Middle East FZE investment in Kura Oncology

Tip: Access up to 7 years of quarterly data

All positions including Kura Oncology held by Point72 Middle East FZE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kura Oncology by Point72 Middle East FZE

Quarter filed Position value Share count Share price at filing
2023-12-31 $293k 20k 14.38
2023-03-31 $6.4k 522 12.23
2022-12-31 $115k 9.2k 12.41

More positions owned by Point72 Middle East FZE

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
General Motors Company (GM)
Eli Lilly & Co. (LLY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Caterpillar Call Option (CAT)
UnitedHealth (UNH)
Amazon (AMZN)
Jd.com Spon Adr Cl A (JD)
Lauder Estee Cos Cl A Call Option (EL)
Target Corporation Call Option (TGT)
At&t (T)
Analog Devices Call Option (ADI)
Synopsys (SNPS)

View all positions for Point72 Middle East FZE

Top funds holding Kura Oncology

BVF
EcoR1 Capital
Deerfield Management Company
Vanguard Group
venBio Select Advisor
Holocene Advisors
Dimensional Fund Advisors
Artal Group
Franklin Resources
Paradigm Biocapital Advisors
Commodore Capital
Assenagon Asset Management
Citadel Advisors
Bank of America Corporation
Sphera Funds Management

View all funds holding Kura Oncology